SEC Form SC 13G/A filed by CorMedix Inc. (Amendment)

CorMedix Inc.

(Name of Issuer)

Common stock, par value $0.001 per share

(Title of Class of Securities)

21900C308

(CUSIP Number)

December 31, 2023

(Date of Event which Requires Filing of this Statement)

(1)	This represents 2,946,531 shares of Common Stock beneficially owned by Nomura Global Financial Products, Inc. (“NGFP”). NGFP is a wholly owned subsidiary of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the shares of Common Stock beneficially owned by NGFP.

(2)	The percent of class is calculated based on 54,812,042 shares of Common Stock issued and outstanding as of November 10, 2023, as reported in the Issuer’s quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2023 filed with the SEC on November 14, 2023.

(3)	The percent of class is calculated based on 54,812,042 shares of Common Stock issued and outstanding as of November 10, 2023, as reported in the Issuer’s quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2023 filed with the SEC on November 14, 2023.

Item 1.	(a)	Name of Issuer:
		CorMedix Inc. (the “Issuer”)
	(b)	Address of Issuer's Principal Executive Offices:
		300 Connell Drive, Suite 4200
		Berkeley Heights, NJ 07922

Item 2.	(a)	Name of Person(s) Filing:
		Nomura Holdings, Inc.
		Nomura Global Financial Products, Inc.
	(b)	Address of Principal Business Office or, if none, Residence:
		Nomura Holdings, Inc.
		13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan
		Nomura Global Financial Products, Inc.
		Worldwide Plaza
		309 West 49th Street
		New York, NY 10019
	(c)	Citizenship:
		Nomura Holdings, Inc.
		Japan
		Nomura Global Financial Products, Inc.
		Delaware
	(d)	Title of Class of Securities:
		Common Stock, par value $0.001 per share (“Common Stock”)
	(e)	CUSIP Number:
		21900C308

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	☒	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
	(b)	☐	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c)	☐	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
	(d)	☐	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
	(e)	☐	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	☐	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	☒	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	☐	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	☐	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	☐	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
	(k)	☐	Group, in accordance with § 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________

Item 4.

Ownership.

Item 5.

Ownership of Five Percent or Less of a Class.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Item 8.

Identification and Classification of Members of the Group.

Item 9.

Notice of Dissolution of Group.

Item 10.

Certification.

	Nomura Holdings, Inc.
	/s/ Samir Patel
	Name:  Samir Patel
	Title:  Managing Director
	Nomura Global Financial Products, Inc.
	/s/ Samir Patel
	Name:  Samir Patel
	Title:  Authorized Officer

Exhibit	Exhibit
A	Joint Filing Agreement
B	Subsidiaries

Nomura Holdings, Inc.
/s/ Samir Patel
Name:  Samir Patel
Title:  Managing Director
Nomura Global Financial Products, Inc.
/s/ Samir Patel
Name:  Samir Patel
Title:  Authorized Officer